Thomas Hutson, DO, PharmD, reviews the case of a 70-year old woman who presents with symptomatic, metastatic clear cell renal cell carcinoma.
All-cause mortality was significantly higher among renal cell carcinoma (RCC) patients who developed symptomatic venous thromboembolism (VTE) after undergoing nephrectomy and inferior vena cava (IVC) tumor thrombectomy (TT) accompanied by intravascular tumor thrombosis, a retrospective analysis showed.
Testing of dozens of the most popular packaged foods for babies and toddlers turned up noticeable and even “worrisome” levels of lead and other heavy metals, according to the watchdog Consumer Reports. Over the course of a child's development, exposure to heavy metals increases the likelihood of developing cancer, particularly lung cancer, bladder cancer and kidney cancer, and increases the risks of issues with neurological development,
Patients with untreated metastatic renal cell carcinoma (mRCC) had significantly better survival with surgery rather than targeted therapy as the initial treatment, a retrospective review of 15,000 patients showed.
In this video, doctors discuss Cabozantinib in mRCC.
This video discusses disease progression in patients with metastatic RCC.
Robots now assist surgeons with kidney cancer, difficult hernias and gynecologic cancers. Robot-assisted surgeries have the best outcomes and are most justified for hard-to-reach areas of the body, such as for prostate removal and head and neck surgeries, according to a 2016 study published in The Milbank Quarterly, a scholarly journal.
Medical studies have linked PFAS in drinking water to kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, pancreatic cancer and birth defects.
According to a study, a blood test could predict kidney cancer risk and survival, five years prior to its diagnosis.
Researchers from Wellcome Sanger Institute, the University of Cambridge and the University of Newcastle discovered that adult renal carcinoma cells are a version of a specific rare subtype of healthy adult kidney cell, called PT1. They found that despite genetic differences, all the renal carcinoma cells studied had developed the same PT1 characteristics. These results could provide the basis of a new method for treating cancer by targeting the PT1 cell specifically.